Subclinical atherosclerosis in scleroderma patients

References

• LeRoy EC. Systemic sclerosis. A vascular perspective. Rheum Dis Clin North Am 1996;22:675–94.
   PubMed Web of Science ®Google Scholar
• Wildt M, Hesselstrand R, Akesson A, Scheja A. Simple counting of nailfold capillary density in suspected systemic sclerosis – 9 years’ experience. Scand J Rheumatol 2007;36:452–7.
   PubMed Web of Science ®Google Scholar
• Veale DJ, Collidge TA, Belch JJ. Increased prevalence of symptomatic macrovascular disease in systemic sclerosis. Ann Rheum Dis 1995;54:853–5.
   PubMedGoogle Scholar
• Stafford L, Englert H, Gover J, Bertouch J. Distribution of macrovascular disease in scleroderma. Ann Rheum Dis 1998;57:476–9.
   PubMed Web of Science ®Google Scholar
• Ho M, Veale D, Eastmond C, Nuki G, Belch J. Macrovascular disease and systemic sclerosis. Ann Rheum Dis 2000;59:39–43.
   PubMed Web of Science ®Google Scholar
• Hettema ME, Bootsma H, Kallenberg CG. Macrovascular disease and atherosclerosis in SSc. Rheumatology (Oxford) 2008;47:578–83.
   PubMed Web of Science ®Google Scholar
• Kampolis C, Plastiras S, Vlachoyiannopoulos P, Moyssakis I, Tzelepis G. The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis. Scand J Rheumatol 2008;37:278–83.
   PubMed Web of Science ®Google Scholar
• Bryan C, Howard Y, Brennan P, Black C, Silman A. Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Br J Rheumatol 1996;35:1122–6.
   PubMedGoogle Scholar
• Borba EF, Borges CT, Bonfá E. Lipoprotein profile in limited systemic sclerosis. Rheumatol Int 2005;25:379–83.
   PubMed Web of Science ®Google Scholar
• Kotyla PJ, Gozdzik J, Lewicki M, Kotulska AT, Kucharz EJ. Serum lipid profile in patients with systemic sclerosis: relationship to the thyreometabolic state. Rheumatol Int 2006;26:583–4.
   PubMedGoogle Scholar
• Lippi G, Caramaschi P, Montagnana M, Salvagno GL, Volpe A, Guidi G. Lipoprotein(a) and the lipid profile in patients with systemic sclerosis. Clin Chim Acta 2006;364:345–8.
   PubMedGoogle Scholar
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581–90.
   PubMed Web of Science ®Google Scholar
• Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Miltiadous G, Goudevenos JA, Altered distribution of platelet-activating factor: acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia. J Lipid Res 2002;43:256–63.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
   PubMed Web of Science ®Google Scholar
• LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202–5.
   PubMed Web of Science ®Google Scholar
• Park YB, Ahn CW, Choi HK, Lee SH, In BH, Lee HC, Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 2002;46:1714–19.
   PubMedGoogle Scholar
• Szucs G, Tímár O, Szekanecz Z, Dér H, Kerekes G, Szamosi S, Endothelial dysfunction precedes atherosclerosis in systemic sclerosis: relevance for prevention of vascular complications. Rheumatology (Oxford) 2007;46:759–62.
   PubMed Web of Science ®Google Scholar
• Bartoli F, Blagojevic J, Bacci M, Fiori G, Tempestini A, Conforti ML, Flow-mediated vasodilation and carotid intima–media thickness in systemic sclerosis. Ann N Y Acad Sci 2007;1108:283–90.
   PubMedGoogle Scholar
• Sherer Y, Cerinic MM, Bartoli F, Blagojevic J, Conforti ML, Gilburd B, Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis. Ann N Y Acad Sci 2007;1108:259–67.
   PubMedGoogle Scholar
• Roman MJ, Moeller E, Davis A, Paget SA, Crow MK, Lockshin MD, Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 2006;144:249–56.
   PubMed Web of Science ®Google Scholar
• Grover S, Sinha RP, Singh U, Tewari S, Aggarwal A, Misra R. Subclinical atherosclerosis in rheumatoid arthritis in India. J Rheumatol 2006;33:244–7.
   PubMedGoogle Scholar
• Kumeda Y, Inaba M, Goto H, Nagata M, Henmi Y, Furumitsu Y, Increased thickness of the arterial intima–media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 2002;46:1489–97.
   PubMed Web of Science ®Google Scholar
• Georgiadis AN, Papavasiliou EC, Lourida ES, Alamanos Y, Kostara C, Tselepis AD, Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment: a prospective, controlled study. Arthritis Res Ther 2006;8:R82.
   PubMed Web of Science ®Google Scholar
• Georgiadis AN, Voulgari PV, Argyropoulou MI, Alamanos Y, Elisaf M, Tselepis AD, Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients. Semin Arthritis Rheum 2008;38:13–19.
   PubMedGoogle Scholar
• Cheng KS, Tiwari A, Boutin A, Denton CP, Black CM, Morris R, Carotid and femoral arterial wall mechanics in scleroderma. Rheumatology (Oxford) 2003;42:1299–305.
   PubMed Web of Science ®Google Scholar
• Mok M, Chiu S, Lo Y, Mak H, Wong W, Khong P, Lau C. Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis. Scand J Rheumatol 2009;38:381–5.
   PubMed Web of Science ®Google Scholar
• Hettema ME, Zhang D, de Leeuw K, Stienstra Y, Smit AJ, Kallenberg CG, Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors. Arthritis Res Ther 2008;10:R49.
   PubMed Web of Science ®Google Scholar